Company Quick10K Filing
Tropic International
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 58 $86
10-Q 2020-01-22 Quarter: 2019-11-30
10-K 2019-12-02 Annual: 2019-08-31
10-Q 2019-07-16 Quarter: 2019-05-31
10-Q 2019-04-19 Quarter: 2019-02-28
10-Q 2019-01-18 Quarter: 2018-11-30
10-K 2018-12-14 Annual: 2018-08-31
10-Q 2018-07-19 Quarter: 2018-05-31
10-Q 2018-04-19 Quarter: 2018-02-28
10-Q 2018-01-22 Quarter: 2017-11-30
10-K 2017-12-15 Annual: 2017-08-31
10-Q 2017-07-19 Quarter: 2017-05-31
10-Q 2017-04-17 Quarter: 2017-02-28
10-Q 2017-01-19 Quarter: 2016-11-30
10-K 2016-12-14 Annual: 2016-08-31
10-Q 2016-07-15 Quarter: 2016-05-31
10-Q 2016-04-14 Quarter: 2016-02-29
10-Q 2016-01-14 Quarter: 2015-11-30
10-K 2015-11-30 Annual: 2015-08-31
10-Q 2015-07-13 Quarter: 2015-05-31
10-Q 2015-04-14 Quarter: 2015-02-28
10-Q 2015-01-13 Quarter: 2014-11-30
10-K 2014-11-28 Annual: 2014-08-31
10-Q 2014-07-15 Quarter: 2014-05-31
10-Q 2014-04-18 Quarter: 2014-02-28
10-Q 2014-01-14 Quarter: 2013-11-30
10-K 2013-12-09 Annual: 2013-08-31
10-Q 2013-06-20 Quarter: 2013-04-30
10-Q 2013-03-18 Quarter: 2013-01-31
10-K 2013-01-29 Annual: 2012-10-31
10-Q 2012-09-19 Quarter: 2012-07-31
10-Q 2012-06-21 Quarter: 2012-04-30
10-Q 2012-03-21 Quarter: 2012-01-31
10-K 2012-02-13 Annual: 2011-10-31
10-Q 2011-09-16 Quarter: 2011-07-31
10-Q 2011-06-20 Quarter: 2011-04-30
10-Q 2011-04-14 Quarter: 2011-01-31
10-K 2011-03-28 Annual: 2010-10-31
8-K 2019-12-01 Enter Agreement, Exhibits
8-K 2019-07-19 Enter Agreement
8-K 2019-03-29 Accountant, Exhibits
8-K 2018-12-27 Other Events
8-K 2018-12-07 Other Events
8-K 2018-11-19 Amend Bylaw, Other Events, Exhibits

Tropic International Financials

TRPO Metrics, Comps, Filings

Annual | Quarterly

Business

We are a company in the business of developing and commercializing innovative technologies. Through Notox, we own 100% of the right, title and interest in and to the License Agreement with the Clinic formerly held by ZHC. The License Agreement grants us the exclusive license to certain patented intellectual property of the Clinic relating to the treatment of a neuromuscular defect developed by Dr. Frank Papay, MD, FACS Chairman Dermatology and Plastic Surgery Institute, Cleveland Clinic, and in particular, the ability to produce, sell, improve and modernize products that incorporate such intellectual property in the fields of aesthetics, drug free pain management, body contouring and perspiration control. We plan to develop this intellectual property into the world's first credible and healthier non-toxic alternative to Botox, which is a commercial form of the botulinum toxin protein used primarily for medical and cosmetic purposes.

Through Tropic Spa, we have finalized the design of a personal tanning product and applied for and acquired patents for it in the United States (the “US Patent”), Canada, Australia and China. The product consists of a unique tanning system designed for spas, gyms, clinics and convenient home use that delivers a full-body application and eliminates the harmful health effects associated with traditional tanning beds, and in particular, exposure to ultraviolet (UV) radiation. We are currently seeking to establish licensing opportunities for Tropic Spa's intellectual property, but have not entered into any formal arrangements as of the date of this Report.

We were incorporated as “Rockford Minerals Inc.” under the laws of the State of Nevada on October 29, 2007. From our inception until the closing of the Share Exchange, we sought to be a producer of gold and silver ore, and of other precious metals. On July 19, 2008, we acquired an undeveloped mining claim called the Rockford Lode Mining Claim located in Clark County, Nevada, for which we paid $12,000, including the cost of a geological report prepared by Sookochoff Consultants Inc. and Laurence Sookochoff, P. Eng., as a consulting geologist, for the purpose of recommending an exploration program. Due to lack of capital, we did not commence any phase of the exploration program recommended in the geological report.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Eaco (EACO) 95,530 28% 6.2 10% 88,765 40,144 215,534 60,071 9,012 14,872 92,780
Ammo (POWW) 95,067 -16% -7.9 -29% 47,937 19,589 6,251 -1,027 -13,754 -11,963 94,528
ChoiceOne Financial Services (COFS) 94,278 0% 7.0 1% 658,497 572,834 3,696 0 6,966 11,438 80,591
Invuity (IVTY) 92,683 67% -2.9 -75% 48,729 46,397 40,834 27,211 -36,461 -31,788 93,415
Nobility Homes (NOBH) 92,404 28% 6.9 14% 55,980 7,733 48,364 13,471 7,750 10,336 71,257
Aerkomm (AKOM) 92,077 3% -11.2 -16% 54,284 10,092 3,345 108 -8,627 -7,677 86,131
NCL (NCLC) 90,687 0% 3.9 6% 15,961,699 9,854,000 6,307,456 0 993,947 1,581,602 6,145,515
Humanigen (HGEN) 90,193 -9.8 -638% 1,587 12,348 0 0 -10,128 -9,042 89,031
Fuse Medical (FZMD) 90,076 56% 15.2 27% 20,652 19,339 24,466 13,808 5,655 5,872 89,234
Mattersight (MATR) 89,019 72% -20.5 -39% 28,863 32,587 50,383 36,274 -11,234 -4,549 93,093
Sunnova Energy (NOVA) 88,611 0% -24.5 -3% 1,952,664 1,403,532 34,612 0 -49,807 -49,807 1,217,907
Tropic International (TRPO) 86,318 -98.1 -69% 1,279 3,897 0 0 -878 -878 86,112
Repro Med Systems (REPR) 85,674 63% 165.2 0% 11,751 2,246 19,141 12,129 24 495 81,866
Liberated Syndication (LSYN) 85,041 85% 9.6 11% 41,949 13,285 23,629 20,008 4,808 8,130 78,435
Community Bancorp (CMTV) 84,712 5.2 1% 679,538 613,866 0 0 8,604 16,180 84,712
Helix TCS (HLIX) 84,486 64% -9.9 -21% 62,076 7,711 10,429 6,630 -12,847 -8,490 83,745
Asia Pacific Boiler (PADR) 81,375 -119.7 -17,358% 4 1,600 0 0 -680 -680 81,375
Cannapharmarx (CPMD) 81,092 -35.8 -23% 21,014 9,282 0 0 -4,841 -2,456 87,996
Parkway Acquisition (PKKW) 79,173 3.9 1% 680,324 601,283 0 0 5,913 11,751 46,111
Intrusion (INTZ) 76,855 62% 17.4 65% 6,415 4,593 12,856 7,912 4,172 4,326 75,378

Balance Sheet ($'000)2011-10-312012-10-312013-08-312014-08-312015-08-312016-08-312017-08-312018-08-31
Cash31112188145636
Accounts Receivable
Inventory16914813112200
PP&E184735343340
Assets315,2374,7374,3214,2971,5231,227
Accounts Payable243138682807529301,412
Long-Term Debt
Liabilities6238633897181,2813,5093,534
Stockholders' Equity-59-375,1754,3483,6043,017-1,986-2,307
Income Statement ($'000)2011-10-312012-10-312013-08-312014-08-312015-08-312016-08-312017-08-312018-08-31
Revenue735100
Cost of Revenue
Gross Profit
R&D
SG&A1425438414357607617804
Tax00000000
Net Income-62-69-782-826-775-1,030-5,072-811
Cash Flow ($'000)2011-10-312012-10-312013-08-312014-08-312015-08-312016-08-312017-08-312018-08-31
Cash Operating-52-53-451-389-136-169-592-112
Cash Investing-24-12-6-15-6660
Cash Financing38515523081323201,17655